Evidence map›Paper›PMID 33327443›Full record

ReviewMicroorganisms2020

Probiotic

María Cámara-Ruiz, María Carmen Balebona, Miguel Ángel Moriñigo, María Ángeles Esteban

Abstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Intestinal Microbial Profiles of Wild Zobaidy (Current issues in molecular biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Combined Dietary Administration ofAnimals : an open access journal from MDPI · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

María Cámara-RuizImmunobiology for Aquaculture Group, Department of Cell Biology and Histology, Faculty of Biology, Campus Regional de Excelencia Internacional "Campus Mare Nostrum", University of Murcia, 30100 Murcia, Spain.
María Carmen BalebonaGroup of Prophylaxis and Biocontrol of Fish Diseases, Department of Microbiology, Campus de Teatinos s/n, University of Malaga, 29071 Málaga, Spain.ORCID 0000-0001-7421-2792
Miguel Ángel MoriñigoGroup of Prophylaxis and Biocontrol of Fish Diseases, Department of Microbiology, Campus de Teatinos s/n, University of Malaga, 29071 Málaga, Spain.
María Ángeles EstebanImmunobiology for Aquaculture Group, Department of Cell Biology and Histology, Faculty of Biology, Campus Regional de Excelencia Internacional "Campus Mare Nostrum", University of Murcia, 30100 Murcia, Spain.ORCID 0000-0002-6264-1458

Funding

Fundación Séneca 19883/GERM/15Ministerio de Economía, Industria y Competitividad, Gobierno de España AGL2017-83370-C3-1-R
6 · The paper itself

Abstract

Aquaculture is considered one of the largest food production sectors in the world. Probiotics have long been considered as a beneficial tool in this industry since these microorganisms improve the welfare of different fish species by modulating several physiological functions, such as metabolism, digestion, immune response, stress tolerance, and disease resistance, among others. SpPdp11, a probiotic isolated from the skin of healthy gilthead seabream, has been the center of attention in a good number of studies since its discovery. The purpose of this paper is to summarize, comment, and discuss the current knowledge related to the effects of SpPdp11 in two commercially important fish species in aquaculture (gilthead seabream and Senegalese sole). Furthermore, some considerations for future studies are also indicated.

Indexed as

gilthead seabreamprobioticsSenegalese soleSpPdp11sustainable aquaculture

Identifiers

PMID33327443
PMCPMC7764857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.